InsiderTrades

Form 4 for PRLB Proto Labs Inc

Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001437749-23-003511 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-15 2023-02-13 PRLB Klaas Bjoern VP, Mng Dir-PL Europe F - Tax $34.23 -1,119 11.4K -9% -$38.3K
D 2023-02-15 2023-02-14 PRLB Klaas Bjoern VP, Mng Dir-PL Europe A - Grant $0.00 +6,649 18.1K +58% $0
DM 2023-02-15 2023-02-14 PRLB Klaas Bjoern VP, Mng Dir-PL Europe A - Grant $0.00 +12.7K 3,048 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-13 F D 1,119 $34.23 11,425 D — —
2 Common Common Stock 2023-02-14 A A 6,649 $0.00 18,074 D — — (F1) Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.
3 Derivative Performance Stock Units 2023-02-14 A A 3,325 $0.00 3,325 D — · — to 2025-12-31 3,325 Common Stock (F2) Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share.
4 Derivative Employee Stock Option (right to buy) 2023-02-14 A A 6,310 $0.00 6,310 D $33.84 · — to 2033-02-14 6,310 Common Stock (F3) 25% of shares subject to the award will vest on February 13, 2024, and on each February 13th thereafter until all shares subject to the award are fully vested.
5 Derivative Employee Stock Option (right to buy) 2023-02-14 A A 3,048 $0.00 3,048 D $33.84 · — to 2026-02-14 3,048 Common Stock (F4) The stock option vests in full on February 13, 2024.